Review: Cardioselective β-blockers did not reduce respiratory function in chronic obstructive pulmonary disease

Stanbrook, Matthew B.
November 2002
ACP Journal Club;Nov/Dec2002, Vol. 137 Issue 3, p104
Academic Journal
Discusses research being done on the effects of cardioselective Î’[sub1]-blockers on the respiratory function of patients with chronic obstructive pulmonary disease. Reference to study by S. Salpeter and colleagues; Sources of data; Physiological effect of the blockers.


Related Articles

  • β-blockers associated with reduced all-cause mortality in COPD. Tashkin, Donald P. // Evidence Based Medicine;Feb2012, Vol. 17 Issue 1, p31 

    The author comments on the article "Effect of Beta Blockers in Treatment of Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study," by PM Short and colleagues published in the "British Medical Journal." He argues that the limitations of the study include those that are common in...

  • β blockers in COPD.  // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;6/5/2010, Vol. 340 Issue 7758, p1227 

    An online discussion concerning a study on the use of Î’ blockers to reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary diseases (COPD) is presented.

  • Should Patients with COPD Exacerbations Receive Beta Blockers? Pierson, David J. // Critical Care Alert;Aug2008, Vol. 16 Issue 5, p37 

    The article presents the findings of a study that utilizes beta blockers on patients with chronic obstructive pulmonary disease (COPD) exacerbations.

  • Use of β blockers in patients with COPD. Au, David H. // Thorax;Apr2008, Vol. 63 Issue 4, p296 

    The article discusses a paper published within this issue about the use of β blockers in patients with chronic obstructive pulmonary disease (COPD).

  • β blockers for adults with chronic obstructive pulmonary disease. Rutten, Frans H.; Groenwold, Rolf H. H. // BMJ: British Medical Journal;1/4/2014, Vol. 348 Issue 7939, p9 

    The author reflects on randomised controlled trials that have already shown that ß blockers reduce mortality following myocardial infarction in the general populations. He cites other observational studies that have suggested thatß blockers may be beneficial for a wider population of...

  • Should Patients with COPD Exacerbations Receive Beta Blockers? Pierson, David J. // Internal Medicine Alert;8/15/2008, Vol. 30 Issue 15, p113 

    The findings of this retrospective study of 825 patients hospitalized with COPD exacerbations indicate that the use of beta blockers in such patients is not harmful and may actually be associated with reduced mortality.

  • 526 Use of beta blockers in HF patients with chronic obstructive pulmonary disease. Lourenco, P.; Mascarenhas, J.; Lopes, R.; Azevedo, A.; Bettencourt, P. // European Journal of Heart Failure. Supplements; 

    The article presents an abstract of the study "Use of Beta Blockers in HF Patients with Chronic Obstructive Pulmonary Disease," by P. Lourenco and colleagues.

  • Impact of coronary angioplasty. Sanfilippo, Filippo; Santonocito, Cristina; Foex, Pierre; Quint, Jennifer K. // BMJ: British Medical Journal;2/1/2014, Vol. 348 Issue 7943, p23 

    A response from the author of the article "Effect of ß Blockers on Mortality After Myocardial Infarction in Adults With COPD: Population Based Cohort Study of UK Electronic Health care Records" in the November 22, 2013 issue, is presented.

  • Safe Beta Blockers in Patients with Reactive Airway Disease. Sadovsky, Richard // American Family Physician;3/1/2003, Vol. 67 Issue 5, p1112 

    Presents a study that analyzed the effect of cardioselective beta blockers on patients with reactive airway disease, including asthma or chronic obstructive pulmonary disease (COPD) with a reversible component. Uses of beta blockers; Contraindications to the use of beta blockers; List of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics